NMDA channel blockers: memantine and amino-aklylcyclohexanes –In vivo characterization
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
The previous overviews provided the basis for better therapeutic efficacy/tolerability of low to moderate affinity NMDA channel blockers. This prediction finds support in in vitro studies comparing protective and plasticity impairing effects (therapeutic vs. side-effect) of memantine and (+)MK-801. In fact it turned out that memantine had a far better therapeutic index. But can it be confirmed in the in vivo situation?
- NMDA channel blockers: memantine and amino-aklylcyclohexanes –In vivo characterization
Volume 19, Issue 1 , pp 167-172
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Keywords: Amino acids
- Channel blockers
- Industry Sectors